Workday
WDAY
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
Lantheus
LNTH
YETI Holdings
YETI
US Stock MarketDetailed Quotes
AAL American Airlines
- 16.985
- +0.085+0.50%
Trading Jan 31 10:28 ET
11.17BMarket Cap13.70P/E (TTM)
17.050High16.910Low3.64MVolume16.950Open16.900Pre Close61.80MTurnover0.56%Turnover Ratio13.70P/E (Static)657.57MShares19.10052wk High-2.81P/B10.96BFloat Cap9.07052wk Low--Dividend TTM645.12MShs Float57.579Historical High--Div YieldTTM0.83%Amplitude8.250Historical Low16.977Avg Price1Lot Size
American Airlines Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 75.01%3.8B | |||||||||
| Net income from continuing operations | ---- | ---- | ---- | ---- | ---- | 547.24%822M | ---- | ---- | ---- | ---- |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 163.18%254M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -1.91%2.25B | ---- | ---- | ---- | ---- |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | 360.00%299M | ---- | ---- | ---- | ---- |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | -186.77%-164M | ---- | ---- | ---- | ---- |
| Change In working capital | ---- | ---- | ---- | ---- | ---- | 229.67%236M | ---- | ---- | ---- | ---- |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | 114.91%95M | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | ---- | ---- | 49.23%873M | ---- | ---- | ---- | ---- |
| -Change in other current assets | ---- | ---- | ---- | ---- | ---- | 98.58%-11M | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | -182.83%-545M | ---- | ---- | ---- | ---- |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | -1,253.85%-176M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 4.73%3.98B | 129.46%398M | 377.59%277M | -36.02%1.13B | -34.59%2.18B | 75.01%3.8B | -755.06%-1.35B | 109.78%58M | 1.38%1.76B | 181.27%3.33B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -92.83%-968M | -59.89%866M | -94.65%58M | 60.38%-376M | 45.78%-1.52B | -178.93%-502M | 39.11%2.16B | 38.27%1.08B | -2.15%-949M | -262.65%-2.8B |
| Capital expenditure reported | -3.35%-2.68B | 12.22%-740M | 8.06%-468M | 11.91%-651M | -63.17%-824M | -1.96%-2.6B | -22.89%-843M | -11.87%-509M | -23.58%-739M | 37.42%-505M |
| Net PPE purchase and sale | 184.35%654M | 409.09%56M | 580.56%245M | ---- | ---- | 56.46%230M | -82.81%11M | -43.75%36M | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | -46.75%819M | -51.86%1.45B | -85.94%206M | 71.89%-131M | 71.52%-702M | -58.60%1.54B | 24.34%3B | 17.48%1.47B | -23,200.00%-466M | -4,664.81%-2.47B |
| Net other investing changes | -25.77%242M | 900.00%104M | -18.48%75M | -27.40%53M | -94.25%10M | 190.81%326M | 89.68%-13M | 237.31%92M | 149.32%73M | 1,066.67%174M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -92.83%-968M | -59.89%866M | -94.65%58M | 60.38%-376M | 45.78%-1.52B | -178.93%-502M | 39.11%2.16B | 38.27%1.08B | -2.15%-949M | -262.65%-2.8B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 12.85%-2.79B | -59.09%-1.3B | 88.49%-142M | -15.51%-715M | -19.11%-642M | -21.85%-3.21B | 36.60%-814M | -389.68%-1.23B | 21.15%-619M | -73.87%-539M |
| Net issuance payments of debt | 3.42%-2.8B | -126.68%-1.35B | 88.55%-137M | -13.81%-684M | -24.50%-625M | -7.94%-2.9B | 55.65%-596M | -371.26%-1.2B | 24.02%-601M | -70.75%-502M |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | 100.97%3M | 125.69%56M | 86.49%-5M | -72.22%-31M | 54.05%-17M | -696.15%-310M | -463.33%-218M | -1,950.00%-37M | -400.00%-18M | -131.25%-37M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 12.85%-2.79B | -59.09%-1.3B | 88.49%-142M | -15.51%-715M | -19.11%-642M | -21.85%-3.21B | 36.60%-814M | -389.68%-1.23B | 21.15%-619M | -73.87%-539M |
| Net cash flow | ||||||||||
| Beginning cash position | 16.21%681M | 35.81%933M | -5.01%740M | 20.38%703M | 16.21%681M | 43.63%586M | 44.33%687M | 45.07%779M | 14.06%584M | 43.63%586M |
| Current changes in cash | 132.63%221M | -416.67%-31M | 309.78%193M | -81.03%37M | 1,200.00%22M | -46.63%95M | -105.45%-6M | -50.82%-92M | 680.00%195M | -101.92%-2M |
| End cash Position | 32.45%902M | 32.45%902M | 35.81%933M | -5.01%740M | 20.38%703M | 16.21%681M | 16.21%681M | 44.33%687M | 45.07%779M | 14.06%584M |
| Free cash flow | 7.71%1.3B | 84.41%-342M | 57.65%-191M | -53.42%477M | -52.05%1.36B | 423.59%1.21B | -159.95%-2.19B | 56.97%-451M | -10.25%1.02B | 648.15%2.83B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |